🔥🐔 BizChicken 🐔🔥

Companies Similar to Savara Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Galera Therapeutics, Inc.

Galera Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

avasopasem manganese (GC4419)

Galera Therapeutics, Inc. is a clinical stage biopharmaceutical company focusing on developing and commercializing therapeutics aimed at transforming radiotherapy in cancer. Their lead product candidate, avasopasem manganese, has completed a Phase III clinical trial targeting oral mucositis in head and neck cancer patients.

Tags: biopharmaceutical, cancer treatment, clinical trials, radiotherapy, superoxide dismutase mimetic

Symbol: GRTX

Recent Price: $0.03

Industry: Biotechnology

CEO: Dr. J. Mel Sorensen M.D.

Sector: Healthcare

Employees: 7

Address: 2 West Liberty Boulevard, Malvern, PA 19355

Phone: 610 725 1500

Leadership

  • J. Mel Sorensen, MD, President and Chief Executive Officer
  • Lawrence Alleva, Chair of the Board of Directors
  • Emmett Cunningham, MD, PhD, Board Member
  • Kevin Lokay, MS, Board Member
  • Michael Powell, PhD, Chair of the Nominating and Corporate Governance Committee
  • Linda West, Chair of the Compensation Committee

Last updated: 2024-12-31

MannKind Corporation

MannKind Corporation logo
Market Cap: High
Employees: Medium

Afrezza

Mann Kind Corporation is a biopharmaceutical company specializing in inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin for diabetes control, and promotes Thyquidity for hypothyroidism treatment.

Tags: biopharmaceutical, diabetes, endocrine diseases, hypothyroidism, inhaled insulin, therapeutic products

Symbol: MNKD

Recent Price: $6.52

Industry: Biotechnology

CEO: Dr. Michael E. Castagna Pharm.D.

Sector: Healthcare

Employees: 411

Address: 30930 Russell Ranch Road, Westlake Village, CA 91362

Phone: 818 661 5000

Last updated: 2024-12-31

Statera Biopharma, Inc.

Statera Biopharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

STAT-201, Entolimod, STAT-401, STAT-205

Statera Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies to treat autoimmune diseases, cancers, and infectious diseases by rebalancing the immune system.

Tags: autoimmune, biopharmaceutical, cancer, immune system, immunotherapy, infectious diseases, novel therapies

Symbol: STAB

Recent Price: $0.00

Industry: Biotechnology

CEO: Mr. Michael Kevin Handley

Sector: Healthcare

Employees: 46

Address: 2537 Research Boulevard, Fort Collins, CO 80526

Phone: 888 613 8802

Last updated: 2024-12-31

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

T-cell immunotherapy treatments

Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.

Tags: Autoimmune Diseases, Biotherapeutics, Cancer Treatment, Immunotherapy, T-Cell Therapy, Viral Diseases

Symbol: ATRA

Recent Price: $13.28

Industry: Biotechnology

CEO: Dr. Anhco Nguyen Ph.D.

Sector: Healthcare

Employees: 165

Address: 611 Gateway Boulevard, South San Francisco, CA 94080

Phone: 650 278 8930

Last updated: 2024-12-31

Astria Therapeutics, Inc.

Astria Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

STAR-0215

Astria Therapeutics, Inc., is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases in the United States. Its lead product candidate, STAR-0215, is targeting hereditary angioedema.

Tags: allergic diseases, biopharmaceutical, hereditary angioedema, immunological diseases, rare diseases

Symbol: ATXS

Recent Price: $8.88

Industry: Biotechnology

CEO: Ms. Jill C. Milne Ph.D.

Sector: Healthcare

Employees: 59

Address: 100 High Street, Boston, MA 02110

Phone: 617 349 1971

Last updated: 2024-12-31

Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

AV-101

Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for rare cardiopulmonary diseases, with a lead product AV-101 for pulmonary arterial hypertension.

Tags: biopharmaceutical, cardiopulmonary diseases, drug development, pulmonary arterial hypertension

Symbol: AVTE

Recent Price: $2.66

Industry: Biotechnology

CEO: Mr. Timothy P. Noyes M.B.A.

Sector: Healthcare

Employees: 51

Address: 930 Winter Street, Waltham, MA 02116

Phone: 617 443 2400

Last updated: 2024-12-31

Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

AVTX-002, AVTX-007, AVTX-801

Avalo Therapeutics, Inc. is a clinical-stage precision medicine company focused on discovering, developing, and commercializing targeted therapeutics for patients with unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases.

Tags: clinical trials, immuno-oncology, immunology, precision medicine, rare genetic diseases, therapeutics

Symbol: AVTX

Recent Price: $7.80

Industry: Biotechnology

CEO: Dr. Garry A. Neil M.D.

Sector: Healthcare

Employees: 19

Address: 540 Gaither Road, Rockville, MD 20850

Phone: 410 522 8707

Leadership

  • Garry A. Neil, MD, Chairman of the Board and Chief Executive Officer
  • Mittie Doyle, MD, FACR, Chief Medical Officer
  • Chris Sullivan, Chief Financial Officer
  • Paul Varki, Chief Legal Officer
  • Lisa Hegg PhD, Senior Vice President, Program Management and Corporate Infrastructure and Clinical Operations
  • Colleen Matkowski, Senior Vice President, Global Regulatory Affairs and Quality Assurance
  • Dino C. Miano, PhD, Senior Vice President, CMC and Technical Operations
  • June Almenoff, MD, PhD, President and Chief Medical Officer
  • Mitchell Chan, Chief Financial Officer
  • Jonathan Goldman, MD, CEO
  • Aaron Kantoff, Managing Partner
  • Gilla Kaplan, PhD, Independent Director
  • Samantha Truex, CEO

Last updated: 2024-12-31

Gossamer Bio, Inc.

Gossamer Bio, Inc. logo
Market Cap: Low
Employees: Low

GB002, GB004, GB5121, GB7208

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.

Tags: biopharmaceutical, central nervous system lymphoma, immunology, inflammation, inflammatory bowel disease, multiple sclerosis, oncology, pulmonary arterial hypertension, therapeutics

Symbol: GOSS

Recent Price: $0.88

Industry: Biotechnology

CEO: Mr. Faheem Hasnain

Sector: Healthcare

Employees: 135

Address: 3013 Science Park Road, San Diego, CA 92121

Phone: 858 684 1300

Leadership

  • Faheem Hasnain, Chairman
  • Richard Aranda, M.D., Chief Medical Officer
  • Jeff Boerneke, General Counsel and Secretary
  • Matt Cravets, Senior Vice President, Biometrics
  • Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
  • Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
  • Caryn Peterson, Executive Vice President, Regulatory Affairs
  • Bob Smith, Chief Commercial Officer
  • Christian Waage, Executive Vice President, Technical Operations & Administration
  • Deanna Weber, Senior Vice President, Human Resources
  • Russell J. Cox, Director
  • Thomas Daniel, Director
  • Skye Drynan, Director
  • Sandra Milligan, Director
  • Steven D. Nathan, Director
  • John Quisel, Director

Last updated: 2024-12-31

Insmed Incorporated

Insmed Incorporated logo
Market Cap: Highest
Employees: Medium

ARIKAYCE, Brensocatib, Treprostinil Palmitil Inhalation Powder

Insmed Incorporated is a biopharmaceutical company founded in 1988, headquartered in Bridgewater, New Jersey. It develops and commercializes therapies for serious and rare diseases, including ARIKAYCE for Mycobacterium avium complex lung disease, Brensocatib for bronchiectasis and neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder for pulmonary arterial hypertension.

Tags: ARIKAYCE, Brensocatib, Treprostinil Palmitil Inhalation Powder, biopharmaceutical, rare diseases, therapies

Symbol: INSM

Recent Price: $68.87

Industry: Biotechnology

CEO: Mr. William H. Lewis J.D., M.B.A.

Sector: Healthcare

Employees: 912

Address: 700 US Highway 202/206, Bridgewater, NJ 08807

Phone: 908 977 9900

Leadership

  • William H. Lewis, J.D., M.B.A., Chair and Chief Executive Officer
  • David R. Brennan, Lead Independent Director
  • Alfred F. Altomari, Director
  • Elizabeth McKee Anderson, Director
  • Clarissa Desjardins, Ph.D., Director
  • Leo Lee, Director
  • David W.J. McGirr, Director
  • Carol A. Schafer, Director
  • Melvin Sharoky, M.D., Director

Last updated: 2024-12-31

Innoviva, Inc.

Innoviva, Inc. logo
Market Cap: Medium
Employees: Low

RELVAR/BREO ELLIPTA, ANORO ELLIPTA, TRELEGY ELLIPTA

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals, focusing on respiratory therapies with its product line including RELVAR/BREO ELLIPTA, ANORO ELLIPTA, and TRELEGY ELLIPTA. The company collaborates with Sarissa Capital Management and Glaxo Group Limited.

Tags: COPD, asthma, partnerships, pharmaceuticals, respiratory therapies

Symbol: INVA

Recent Price: $17.38

Industry: Biotechnology

CEO: Mr. Pavel Raifeld C.F.A.

Sector: Healthcare

Employees: 112

Address: 1350 Old Bayshore Highway, Burlingame, CA 94010

Phone: 650 238 9600

Last updated: 2024-12-31

Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc. logo
Market Cap: Low
Employees: Medium

P-PSMA-101

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on developing innovative CAR-T therapies for patients with high unmet medical needs, including treatments for prostate cancer, multiple myeloma, and various solid tumors.

Tags: CAR-T therapy, biopharmaceutical, cancer treatment, clinical-stage, innovative therapeutics

Symbol: PSTX

Recent Price: $9.48

Industry: Biotechnology

CEO: Dr. Kristin Yarema Ph.D.

Sector: Healthcare

Employees: 337

Address: 9390 Towne Centre Drive, San Diego, CA 92121

Phone: 858 779 3100

Last updated: 2024-12-31

Pulmatrix, Inc.

Pulmatrix, Inc. logo
Market Cap: Lowest
Employees: Lowest

Pulmazole, PUR1800, PUR3100

Pulmatrix, Inc., a clinical stage biotechnology company, develops inhaled therapies for respiratory and other diseases with unmet medical needs, using its i SPERSE technology for drug delivery.

Tags: biotechnology, i SPERSE technology, inhaled therapies, respiratory diseases

Symbol: PULM

Recent Price: $6.86

Industry: Biotechnology

CEO: Mr. Peter Ludlum CMA, MBA

Sector: Healthcare

Employees: 22

Address: 99 Hayden Avenue, Lexington, MA 02421

Phone: 781 357 2333

Last updated: 2024-12-31

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

SAB-185, SAB-176

SAB Biotherapeutics is a clinical-stage biopharmaceutical company focusing on developing immunotherapies based on human antibodies, using advanced genetic engineering to produce fully-human polyclonal antibodies targeting diseases such as COVID-19, influenza, autoimmune disorders, and cancer.

Tags: COVID-19, autoimmune disorders, biopharmaceutical, cancer, human antibodies, immunotherapy, influenza

Symbol: SABS

Recent Price: $4.15

Industry: Biotechnology

CEO: Mr. Samuel J. Reich

Sector: Healthcare

Employees: 57

Address: 2100 East 54th Street North, Sioux Falls, SD 57104

Phone: 605 679 6980

Last updated: 2024-12-31

Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Medium

G-MAB antibody library, Sofusa drug delivery technology, ZTlido

Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focusing on developing therapies for various diseases, including cancer and autoimmune diseases, using innovative antibody libraries and drug delivery systems.

Tags: CAR-T therapy, antibody library, autoimmune diseases, biopharmaceutical, cancer therapy, drug delivery

Symbol: SRNE

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Henry H. Ji Ph.D.

Sector: Healthcare

Employees: 949

Address: 4955 Directors Place, San Diego, CA 92121

Phone: 858 203 4100

Last updated: 2024-12-31

Protara Therapeutics, Inc.

Protara Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

N/A

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

No tags available.

Symbol: TARA

Recent Price: $5.28

Industry: Biotechnology

CEO: Mr. Jesse Shefferman

Sector: Healthcare

Employees: 26

Address: 345 Park Avenue South, New York, NY 10010

Phone: 646 844 0337

Last updated: 2024-12-31

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

resmetirom

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focusing on developing and commercializing therapeutic candidates for cardiovascular, metabolic, and liver diseases, with its lead product candidate resmetirom targeting non-alcoholic steatohepatitis.

Tags: biopharmaceutical, cardiovascular, clinical-stage, liver diseases, metabolic, non-alcoholic steatohepatitis, resmetirom, therapeutic candidates

Symbol: MDGL

Recent Price: $311.62

Industry: Biotechnology

CEO: Mr. William J. Sibold

Sector: Healthcare

Employees: 376

Address: Four Tower Bridge, West Conshohocken, PA 19428

Phone: 267 824 2827

Leadership

  • BILL SIBOLD, Chief Executive Officer
  • REBECCA TAUB, M.D., Director, Founder, Chief Medical Officer and President of Research & Development
  • MARDI C. DIER, Chief Financial Officer
  • CAROLE HUNTSMAN, Chief Commercial Officer
  • CLINT WALLACE, Chief Human Resources Officer
  • RONALD FILIPPO, Chief Information Officer
  • STEPHEN DODGE, PHARM D, M.B.A., Senior Vice President, Global Medical Affairs
  • SHANNON KELLEY, General Counsel
  • MARK BARRETT, Chief Business Officer
  • MARK UNDERWOOD, Senior Vice President, Business Planning & Operations
  • Julian C. Baker, Chairman and Director
  • Kenneth M. Bate, Director
  • Raymond Cheong, M.D., Ph.D., Director
  • Fred Craves, Ph.D., Director
  • James M. Daly, Director
  • Paul A. Friedman, M.D., Director
  • Richard S. Levy, M.D., Director
  • Bill Sibold, Director, Chief Executive Officer
  • Rebecca Taub, M.D., Director, Founder, Chief Medical Officer and President of Research & Development

Last updated: 2024-12-31

PaxMedica, Inc. Common Stock

PaxMedica, Inc. Common Stock logo
Market Cap: Lowest
Employees: Lowest

PAX-101

Pax Medica, Inc., is a clinical stage biopharmaceutical company focused on developing anti-purinergic drug therapies for treating intractable neurologic disorders. Their lead product, PAX-101, is an intravenous formulation of suramin for indications such as autism spectrum disorder and chronic fatigue syndrome.

Tags: Autism Treatment, Biopharmaceutical, Chronic Fatigue Syndrome, Drug Development, Neurologic Disorders

Symbol: PXMD

Recent Price: $0.06

Industry: Biotechnology

CEO: Mr. Howard J. Weisman

Sector: Healthcare

Employees: 6

Address: 303 South Broadway, Tarrytown, NY 10591

Phone: 914-987-2876

Last updated: 2024-12-31

Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010

Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.

Tags: ALS, Parkinson's disease, Sanfilippo syndrome, biopharmaceutical, central nervous system, major depressive disorder, respiratory disorders, therapeutics

Symbol: SEEL

Recent Price: $0.37

Industry: Biotechnology

CEO: Dr. Raj Mehra J.D., Ph.D.

Sector: Healthcare

Employees: 8

Address: 300 Park Avenue, New York, NY 10022

Phone: 646 293 2100

Last updated: 2024-12-31

Savara Inc.

Savara Inc. logo
Market Cap: Medium
Employees: Lowest

Molgramostim

Savara Inc. is a clinical stage biopharmaceutical company focusing on rare respiratory diseases. Their lead product is Molgramostim, an inhaled treatment in Phase III development for autoimmune pulmonary alveolar proteinosis. The company is based in Austin, Texas.

Tags: Molgramostim, autoimmune pulmonary alveolar proteinosis, biopharmaceutical, clinical trials, rare diseases, respiratory diseases

Symbol: SVRA

Recent Price: $3.08

Industry: Biotechnology

CEO: Mr. Matthew Pauls J.D., M.B.A.

Sector: Healthcare

Employees: 37

Address: Building III, Austin, TX 78746

Phone: 512 614 1848

Last updated: 2024-12-31

Avalon GloboCare Corp.

Avalon GloboCare Corp. logo
Market Cap: Lowest
Employees: Lowest

Keto Air™ breathalyzer, AVA-001 CAR-T, AVA-011 CAR-T, ACTEX, QTY-code protein design technology

Avalon Globo Care Corp. is a commercial-stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services as well as medical-related consulting services and research in therapeutics and diagnostics.

Tags: CAR-T Therapy, Clinical Laboratory Services, Exosomes, Immunotherapy, Medical Consulting, Precision Diagnostics, QTY Protein Design, RNA-based Therapy

Symbol: ALBT

Recent Price: $3.43

Industry: Real Estate - Services

CEO: Dr. David K. Jin M.D., Ph.D.

Sector: Real Estate

Employees: 4

Address: 4400 Route 9 South, Freehold, NJ 07728

Phone: 732 780 4400

Leadership

  • David Jin, Chief Executive Officer, President and Director
  • Meng Li, Chief Marketing Officer, Secretary
  • Luisa Ingargiola, Chief Financial Officer
  • Wenzhao Lu, Chairman of the Board
  • Steven Sanders, Esq., Director
  • Lourdes Felix, Director
  • William Stilley, Director
  • Billy Tauzin, Director
  • Dr. Tevi Troy, Director

Last updated: 2024-12-31